GlassScriptPhysician profile
Barry S Merrill
NPI 1740265610
$21,157.03
in general payments reported to CMS, 2019-2025
50 companies · $3,307 in 2025
The $3,307 reported for 2025 was more than what 89% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,279 · 2020: $1,559 · 2021: $3,035 · 2022: $3,405 · 2023: $3,236 · 2024: $3,336 · 2025: $3,307.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,879.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,879.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,210.06 | 2019-2025 | Aveir, Jot Dx, Dragonfly Opstar |
| Novartis Pharmaceuticals Corporation | $1,792.24 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $1,484.36 | 2019-2024 | Xarelto |
| Amgen INC. | $1,416.56 | 2019-2025 | Repatha, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,386.20 | 2019-2025 | Jardiance |
| Abiomed | $1,297.51 | 2019-2024 | Impella |
| Pfizer INC. | $1,296.94 | 2019-2025 | |
| Shockwave Medical, INC | $945.54 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Heartflow, INC. | $941.13 | 2019-2025 | Ffrct |
| Astrazeneca Pharmaceuticals LP | $786.81 | 2019-2025 | Farxiga, Wainua |
| Cardiva Medical, INC. | $676.92 | 2021-2025 | Cardiva Vascade 6/7f Vcs, Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade 5f Vcs |
| E.R. Squibb & Sons, L.L.C. | $618.69 | 2020-2025 | Camzyos, Eliquis |
| Sanofi-Aventis U.S. LLC | $608.51 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $560.29 | 2021-2025 | Verquvo, Capvaxive |
| Amarin Pharma, INC. | $547.28 | 2019-2022 |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $510.82 | 2019-2025 | Watchman Flx |
| Medtronic, INC. | $355.90 | 2021-2025 | Micra, Linq II, Aurora Ev-Icd Mri Surescan |
| Philips North America LLC | $355.87 | 2022-2025 | Ambulatory Monitoring & Diagnostics Undivided, (5091) Amb Mon & Diag Und, (Cm9) Amb Mon & Diag Und |
| Cardiovascular Systems INC. | $288.10 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $268.00 | 2020-2025 | Lifevest |
| Chiesi USA, INC. | $251.40 | 2019-2025 | Kengreal |
| Bayer Healthcare Pharmaceuticals INC. | $249.17 | 2021-2025 | |
| Kowa Pharmaceuticals America, INC. | $228.86 | 2019-2024 | Livalo |
| Cleerly, INC. | $203.63 | 2025 | Cleerly Labs, Cleerly Ischemia |
| Zoll Circulation INC | $198.20 | 2021 | |
| Kestra Medical Technology Services, INC. | $170.85 | 2023-2025 | Assure Wcd |
| Genzyme Corporation | $138.91 | 2019-2023 | |
| Esperion Therapeutics, INC. | $131.76 | 2024-2025 | Nexletol |
| Inari Medical, INC. | $126.35 | 2021 | |
| Alnylam Pharmaceuticals INC. | $118.65 | 2021-2025 | Onpattro |
| Cvrx, INC. | $107.73 | 2023-2025 | Barostim Neo System |
| Lexicon Pharmaceuticals, INC. | $75.41 | 2023 | Inpefa |
| Bridgebio Pharma, INC. | $74.55 | 2025 | Attruby |
| Kiniksa Pharmaceuticals International, Plc | $72.43 | 2024 | Arcalyst |
| Novo Nordisk INC | $70.38 | 2021-2024 | Wegovy |
| Penumbra, INC. | $69.50 | 2021-2024 | Indigo System |
| Agepha Pharma Fz LLC | $60.49 | 2024-2025 | Lodoco |
| Kiniksa Pharmaceuticals, LTD. | $60.03 | 2022-2023 | Arcalyst |
| Getinge USA Sales, LLC | $55.23 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $53.47 | 2019-2025 | Evkeeza, Praluent |
| Bardy Diagnostics, INC. | $50.00 | 2020 | |
| Irhythm Technologies, INC. | $49.21 | 2023 | Zio Xt Patch |
| Vital Connect, INC | $37.76 | 2025 | Vitalpatch Rtm |
| Siemens Medical Solutions USA, INC. | $37.12 | 2020 | |
| Atricure, INC. | $21.84 | 2021 | |
| Amryt Pharma Holdings LTD | $21.02 | 2021 | |
| Akcea Therapeutics, INC. | $20.86 | 2020 | |
| Terumo Medical Corporation | $20.54 | 2019 | |
| Medtronic Vascular, INC. | $17.58 | 2019 | |
| Astellas Pharma US INC | $16.37 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barry Merrill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.